Monitoring Technologies for Quantifying Medication Adherence

Aldeer, Murtadha; Javanmard, Mehdi; Ortiz, Jorge; Martin, Richard P.

doi:10.1007/978-3-030-94212-0_3

Cited by 4 publications

(5 citation statements)

References 86 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To be able to synchronize the collected data with cloud storage, SMAPs without a built-in SIM require one or more of the following short-range communications: wireless near-field communication, which was available on 10% (8/80) of the SMAPs in this review; Bluetooth (11/80, 14%); and cellular data (eg, 2G, 3G, or 4G and long-term evolution), Wi-Fi, or Ethernet on 90% (72/80) of the SMAPs in this review. SMAPs with a built-in SIM, which was available in 10% (8/80) of the products in this review, may require an additional subscription fee; however, they do not require wireless short-range communication (eg, Mymemo or Philips Medication Dispenser) [ 17 , 22 , 42 - 44 ].…”

Section: Resultsmentioning

confidence: 99%

“…Given the rapid development of such technology and how features of different products may need to be considered by clinicians when recommending smart medication adherence technologies, we sought to update a previous review of the features of new SMAPs available for in-home use [ 16 , 17 ]. Information on the available features of SMAPs is especially important to clinicians addressing medication nonadherence among their patients and can assist with the selection of the best-suited product.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Key Features of Smart Medication Adherence Products: Updated Scoping Review

Faisal,

Samoth,

Aslam

et al. 2023

JMIR Aging

View full text Add to dashboard Cite

Background Older adults often face challenges in self-managing their medication owing to physical and cognitive limitations, complex medication regimens, and packaging of medications. Emerging smart medication dispensing and adherence products (SMAPs) offer the options of automated dispensing, tracking medication intake in real time, and reminders and notifications. A 2021 review identified 51 SMAPs owing to the rapid influx of digital technology; an update to this review is required. Objective This review aims to identify new products and summarize and compare the key features of SMAPs. Methods Gray and published literature and videos were searched using Google, YouTube, PubMed, Embase, and Scopus. The first 10 pages of Google and the first 100 results of YouTube were screened using 4 and 5 keyword searches, respectively. SMAPs were included if they were able to store and allowed for the dispensation of medications, tracked real-time medication intake data, and could automatically analyze data. Products were excluded if they were stand-alone software applications, not marketed in English, not for in-home use, or only used in clinical trials. In total, 5 researchers independently screened and extracted the data. Results This review identified 114 SMAPs, including 80 (70.2%) marketed and 34 (29.8%) prototypes, grouped into 15 types. Among the marketed products, 68% (54/80) were available for consumer purchase. Of these products, 26% (14/54) were available worldwide and 78% (42/54) were available in North America. There was variability in the hardware, software, data collection and management features, and cost of the products. Examples of hardware features include battery life, medication storage capacity, availability of types and number of alarms, locking features, and additional technology required for use of the product, whereas software features included reminder and notification capabilities and availability of manufacturer support. Data capture methods included the availability of sensors to record the use of the product and data-syncing capabilities with cloud storage with short-range communications. Data were accessible to users via mobile apps or web-based portals. Some SMAPs provided data security assurance with secure log-ins (use of personal identification numbers or facial recognition), whereas other SMAPs provided data through registered email addresses. Although some SMAPs were available at set prices or free of cost to end users, the cost of other products varied based on availability, shipping fees, and subscription fees. Conclusions An expanding market for SMAPs with features specific to at-home patient use is emerging. Health care professionals can use these features to select and suggest products that meet their patients’ unique requirements.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Key Features of Smart Medication Adherence Products: Updated Scoping Review

Faisal,

Samoth,

Aslam

et al. 2023

JMIR Aging

View full text Add to dashboard Cite

show abstract

“…This study focuses on the impact of IoT technologies in medication adherence monitoring systems, which serve as indirect approaches for measuring PMA. As a result, evaluation of the PMA was purposely deleted from the subsequent study, owing to its majority location outside the domain of psychological and social sciences (Aldeer et al, 2022). It is worth noting that most of the IoT technologies mentioned in the selected research are efficient.…”

Section: Data Extraction and Synthesismentioning

confidence: 99%

“…It is worth noting that most of the IoT technologies mentioned in the selected research are efficient. However, no gold-standard measurement system currently meets the requirements for optimal monitoring (Aldeer et al, 2022;Stegemann et al, 2012).…”

Section: Data Extraction and Synthesismentioning

confidence: 99%

“…These IoT solutions include various tools, ranging from intelligent pillboxes and wearable technology to mobile health apps, all geared to meet the diverse needs of the patient population. Furthermore, empirical evidence suggests that adopting such IoT technology significantly increases medication adherence, particularly among patients with chronic health conditions (Aldeer et al, 2022;Awotunde et al, 2021;Ghozali, 2023). This meeting of healthcare and technology, utilising IoT as a conduit, is revolutionising patient care and ushering in a new era of medication administration.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Implementation of the IoT-Based Technology on Patient Medication Adherence: A Comprehensive Bibliometric and Systematic Review

Ghozali

2023

Journal of Information and Communication Technology

View full text Add to dashboard Cite

The dynamic field of the Internet of Things (IoT) is constantly increasing, providing a plethora of potential integration across various sectors, most notably healthcare. The IoT represents a significant technological leap in healthcare management systems, coinciding with the rising preference for personalized, proactive, cost-effective treatment techniques. This review aimed to thoroughly assess the existing literature through a systematic review and bibliometric analysis, identifying untapped research routes and possible domains for further exploration. The overarching goal was to provide healthcare professionals with significant insights into the impact of IoT technology on Patient Medication Adherence (PMA) and related outcomes. An extensive review of 314 scientific articles on the deployment of IoT within pharmaceutical care services revealed a rising trend in publication volume, with a significant increase in recent years. Pertinently, from the 33 publications finally selected, substantial data support the potential of the IoT to improve PMA, particularly among senior patients with chronic conditions. This paper also comments on various regularly implemented IoT-based systems, noting their unique benefits and limitations. In conclusion, the critical relevance of PMA is highlighted, arguing for its emphasis in future discussions. Furthermore, the need for additional research endeavors is proposed to face and overcome existing constraints and establish the long-term effectiveness of IoT technologies in maximizing patient outcomes.

show abstract